GlobeNewswire Inc.··Euda Health Holdings LimitedEUDA Partner Secures Shenzhen R&D Funding for TCR-T Cell Therapy Development
EUDA's partner Shenzhen Inno Immune wins Chinese government R&D funding approval for TCR-T cell therapy development targeting solid tumors.
EUDAEUDAWcancer treatmentsolid tumors